KADCYLA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Ado-trastuzumab Emtansine.
Product ID | 50242-088_025ce8f1-7c1e-4926-9657-daaa1e213dff |
NDC | 50242-088 |
Product Type | Human Prescription Drug |
Proprietary Name | KADCYLA |
Generic Name | Ado-trastuzumab Emtansine |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2013-02-22 |
Marketing Category | BLA / BLA |
Application Number | BLA125427 |
Labeler Name | Genentech, Inc. |
Substance Name | ADO-TRASTUZUMAB EMTANSINE |
Active Ingredient Strength | 20 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-02-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125427 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-02-22 |
Ingredient | Strength |
---|---|
ADO-TRASTUZUMAB EMTANSINE | 20 mg/mL |
SPL SET ID: | 23f3c1f4-0fc8-4804-a9e3-04cf25dd302e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50242-087 | KADCYLA | ADO-TRASTUZUMAB EMTANSINE |
50242-088 | KADCYLA | ADO-TRASTUZUMAB EMTANSINE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KADCYLA 85163874 not registered Dead/Abandoned |
GENENTECH, INC. 2010-10-28 |
KADCYLA 77962556 4347053 Live/Registered |
Genentech, Inc. 2010-03-18 |